Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;9(3):209-214.
doi: 10.1177/2048872620922790. Epub 2020 May 4.

Medical treatment options for COVID-19

Leen Delang  1   2 , Johan Neyts  1   2
Affiliations
Review

Medical treatment options for COVID-19

Leen Delang et al. Eur Heart J Acute Cardiovasc Care. 2020 Apr.

Abstract

Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs and immunomodulators might have their place in the management of coronavirus disease 2019. Unfortunately, no drugs have been approved yet to treat infections with human coronaviruses. As it will take years to develop new therapies for severe acute respiratory syndrome coronavirus 2, the current focus is on the repurposing of drugs that have been approved or are in development for other conditions. Several clinical trials have already been conducted or are currently ongoing to evaluate the efficacy of such drugs. Here, we discuss the potential of these therapies for the treatment of coronavirus disease 2019.

Keywords: COVID-19; SARS-CoV-2; antiviral drugs; immunomodulators; treatment.

PubMed Disclaimer

References

    1. World Health Organization. Report of the WHO – China Joint Mission on Coronavirus Disease 2019 (COVID-19) Geneva: WHO, 2020.
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497. - PMC - PubMed
    1. Belhadi D, Peiffer-Smadja N, Yazdanpanah Y, et al. A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19. medRxiv. Epub ahead of print 18 March 2020. DOI: 2020.03.18.20038190.
    1. Kupferschmidt K. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine 2020. Available at: https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-fo... (accessed 21 April 2020).
    1. Touret F, de Lamballerie X Of chloroquine and COVID-19. Antiviral Res 2020; 177: 104762. - PMC - PubMed

MeSH terms